pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
Ultragenyx Pharmaceutical Inc. ($RARE) · news · pharmadog
← back to Ultragenyx Pharmaceutical Inc.
News mentioning $RARE
835
stories
Aug 3, 26
BioNTech taps Sobi executive Oelkers as its next CEO
biopharma dive
Aug 3, 26
Boticelli Foods Recalls Bettergoods Pistachio Nut Butter Because of Possible Health Risk
fda recalls
Aug 3, 26
Amgen hit with cybersecurity breach, patient data affected
biospace
Aug 3, 26
Heart transplant candidates fail if they get too weak. New program tries inpatient prehab
stat
Aug 3, 26
STAT+: Are AI scribes useful tools in medical education, or a crutch that imperils learning?
stat
Aug 3, 26
Biotech leaders call for streamlining of INDs as FDA’s Trialblazer rolls out
biospace
Aug 3, 26
5 companies advancing ATTR assets in the wake of Wainua’s fail
biospace
Aug 3, 26
Editor’s Corner: Why an AstraZeneca-Bristol Myers Squibb merger is a bad idea
fiercebiotech
Jul 31, 26
Capricor CEO won’t rule out legal action against FDA after negative adcomm
biospace
Jul 31, 26
Moderna maintains 10% growth target despite Phase 3 norovirus miss
biospace
Jul 31, 26
Alnylam absorbs $10.8B blowback after cutting full-year guidance for TTR franchise
biospace
Jul 31, 26
UniQure welcomes possible adcomm for Huntington’s asset as regulatory ‘jitters’ spread through biopharma
biospace
Jul 31, 26
Federal government could improve infectious disease monitoring, says federal government
stat
Jul 31, 26
Novo Nordisk left praying to Artemis and Hermes to salvage CKD program after phase 3 fail
fiercebiotech
Jul 31, 26
Opinion: Limb girdle muscular dystrophy patients face a maddening reality
stat
Jul 30, 26
Alnylam plunges as earnings deliver ‘one-two punch’
biopharma dive
Jul 30, 26
Capricor’s data clash and a fugitive in the C-suite
stat
Jul 30, 26
Chutes & Ladders—Legend CEO departs without successor in place
fiercebiotech
Jul 30, 26
STAT+: Pharmalittle: We’re reading about an FDA panel nixing a Duchenne drug, FTC suing Hims & Hers, and more
stat
Jul 30, 26
Opinion: U.S. dependence on China is a national security risk
stat
Jul 30, 26
Chronically ill people face confusion over new Medicaid work rules and ‘medically frail’ exemption
stat
Jul 30, 26
New funding, new jobs: 4 biotechs hiring after series B raises
biospace
Jul 30, 26
Sanofi’s new CEO ‘looking deeply’ at late-stage pipeline as clinical clearout continues
fiercebiotech
Jul 30, 26
Biogen validated the Alzheimer’s tau theory. CEO Viehbacher still isn’t betting the store
biospace
Jul 30, 26
Is it safe to drink Red Bull and alcohol? Questionable research tied to energy drink giant has shaped policy
stat
Jul 29, 26
FDA advisers vote against approval of Capricor’s DMD therapy in chaotic adcomm meeting
biospace
Jul 29, 26
FDA reviewers vote against approval of Capricor’s DMD therapy in chaotic adcomm meeting
biospace
Jul 29, 26
Capricor Duchenne cell therapy voted down by FDA panel
biopharma dive
Jul 29, 26
MapLight CEO on what investors missed in the biotech’s schizophrenia data
biopharma dive
Jul 29, 26
Private biotechs Caldera and Vidya raise $478M collectively in reverse go-public mergers
biospace
← prev
page 16 of 28
next →
